Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page update appears to be a cosmetic/layout change with no alteration to core study information (title, eligibility criteria, interventions, outcomes, contacts, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:53:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    6%
    Check dated 2025-10-06T05:16:06.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Core page content remains the same; added contact details (phone numbers and email) and updated version to v3.1.0. Removed version v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.3%
    Check dated 2025-09-14T18:54:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.3%
    Check dated 2025-09-07T13:54:58.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location in Petah Tikva, Israel, while removing various medical terms and references related to neoplasms and infections.
    Difference
    7%
    Check dated 2025-08-31T11:35:50.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.